Cargando…

Adverse events of high-dose tigecycline in the treatment of ventilator-associated pneumonia due to multidrug-resistant pathogens

The off-label uses of tigecycline (TGC) to treat ventilator-associated pneumonia (VAP) have aroused worldwide concerns. The efficacy about TGC has been recently reported. However, the adverse events (AEs) remain controversial. Our study aims to analyze the safety of the high-dose (HD) regimens in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Zihan, Shi, Xiaoyan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer Health 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6160260/ https://www.ncbi.nlm.nih.gov/pubmed/30235740 http://dx.doi.org/10.1097/MD.0000000000012467

Ejemplares similares

High-Dose Tigecycline in Elderly Patients with Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii in Intensive Care Unit
por: Bai, Xiang-Rong, et al.
Publicado: (2020)

High dose tigecycline in critically ill patients with severe infections due to multidrug-resistant bacteria
por: De Pascale, Gennaro, et al.
Publicado: (2014)

Successful High-Dosage Monotherapy of Tigecycline in a Multidrug-Resistant Klebsiella pneumoniae Pneumonia–Septicemia Model in Rats
por: Van der Weide, Hessel, et al.
Publicado: (2020)

Best tigecycline dosing for treatment of infections caused by multidrug-resistant pathogens in critically ill patients with different body weights
por: Ibrahim, Mohamed M, et al.
Publicado: (2018)

High dose of tigecycline for extremely resistant Gram-negative pneumonia: yes, we can
por: Garnacho-Montero, José, et al.
Publicado: (2014)

Emergence of Ceftazidime/Avibactam and Tigecycline Resistance in Carbapenem-Resistant Klebsiella pneumoniae Due to In-Host Microevolution
por: Han, Xinhong, et al.
Publicado: (2021)

Tigecycline in the Treatment of Ventilator-Associated Pneumonia Due to Stenotrophomonas maltophilia: A Multicenter Retrospective Cohort Study
por: Zha, Lei, et al.
Publicado: (2021)

Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii
por: Zhou, Yangang, et al.
Publicado: (2019)

Sulbactam combined with tigecycline improves outcomes in patients with severe multidrug-resistant Acinetobacter baumannii pneumonia
por: Deng, Yanling, et al.
Publicado: (2022)

Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline Evaluation and Surveillance Trial
por: Giammanco, Anna, et al.
Publicado: (2017)

Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia
por: Depuydt, Pieter O, et al.
Publicado: (2008)

Characterization of two multidrug-resistant Klebsiella pneumoniae harboring tigecycline-resistant gene tet(X4) in China
por: Yang, Yanxian, et al.
Publicado: (2023)

Outcomes and prognostic factors of tigecycline treatment for hospital-acquired pneumonia involving multidrug-resistant Acinetobacter baumannii
por: Liu, Ben, et al.
Publicado: (2020)

Polymyxin B, Cefoperazone Sodium-Sulbactam Sodium, and Tigecycline against Multidrug-Resistant Acinetobacter baumannii Pneumonia
por: Hu, Guangxue, et al.
Publicado: (2022)

Colistin and tigecycline for management of external ventricular device-related ventriculitis due to multidrug-resistant Acinetobacter baumannii
por: Shrestha, Gentle Sunder, et al.
Publicado: (2016)

Tigecycline Susceptibility and the Role of Efflux Pumps in Tigecycline Resistance in KPC-Producing Klebsiella pneumoniae
por: He, Fang, et al.
Publicado: (2015)

Preliminary experience of tigecycline treatment in critically ill children with ventilator-associated pneumonia
por: Lin, Shupeng, et al.
Publicado: (2018)

Diagnosis of Multidrug-Resistant Pathogens of Pneumonia
por: Sfeir, Maroun M.
Publicado: (2021)

Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis
por: Xia, Guolian, et al.
Publicado: (2020)

A Novel Tigecycline Adjuvant ML-7 Reverses the Susceptibility of Tigecycline-Resistant Klebsiella pneumoniae
por: Sun, Lilan, et al.
Publicado: (2022)

Clinical Outcomes of Tigecycline in the Treatment of Multidrug-Resistant Acinetobacter baumannii Infection
por: Shin, Jung Ar, et al.
Publicado: (2012)

Multidrug resistant Acinetobacter nosocomial meningitis treated successfully with parenteral tigecycline
por: Wadi, Jamal Ahmad, et al.
Publicado: (2007)

Ventilator-associated pneumonia caused by multidrug resistant bacteria
por: Sartzi, M, et al.
Publicado: (2005)

Three Dimensional Checkerboard Synergy Analysis of Colistin, Meropenem, Tigecycline against Multidrug-Resistant Clinical Klebsiella pneumonia Isolates
por: Stein, Claudia, et al.
Publicado: (2015)

Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex
por: Ye, Jung-Jr, et al.
Publicado: (2016)

High-dose tigecycline use in severe infections
por: De Pascale, G, et al.
Publicado: (2013)

Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients
por: Kim, Won-Young, et al.
Publicado: (2016)

Impacts of Multidrug-Resistant Pathogens and Inappropriate Initial Antibiotic Therapy on the Outcomes of Neonates with Ventilator-Associated Pneumonia
por: Wang, Hsiao-Chin, et al.
Publicado: (2020)

High-dose tigecycline for the treatment of nosocomial carbapenem-resistant Klebsiella pneumoniae bloodstream infections: A retrospective cohort study
por: Geng, Ting-Ting, et al.
Publicado: (2018)

Intravenous Polymyxin B as Adjunctive Therapy to High-Dose Tigecycline for the Treatment of Nosocomial Pneumonia Due to Carbapenem-Resistant Acinetobacter baumannii and Klebsiella pneumoniae: A Propensity Score-Matched Cohort Study
por: Zha, Lei, et al.
Publicado: (2023)

Complete Genome Sequence of Klebsiella pneumoniae Sequence Type 17, a Multidrug-Resistant Strain Isolated during Tigecycline Treatment
por: Hua, Xiaoting, et al.
Publicado: (2014)

Clinical Features and Outcomes of Monobacterial and Polybacterial Episodes of Ventilator-Associated Pneumonia Due to Multidrug-Resistant Acinetobacter baumannii
por: Adukauskiene, Dalia, et al.
Publicado: (2022)

Evolution of tigecycline resistance in Klebsiella pneumoniae in a single patient
por: Al-Qadheeb, Nada S., et al.
Publicado: (2010)

Once Daily High Dose Tigecycline Is Optimal: Tigecycline PK/PD Parameters Predict Clinical Effectiveness
por: Baron, Jeffrey, et al.
Publicado: (2018)

In vitro activity of tigecycline in combination with various antimicrobials against multidrug resistant Acinetobacter baumannii
por: Principe, Luigi, et al.
Publicado: (2009)

Sensitivity of levofloxacin in combination with ampicillin-sulbactam and tigecycline against multidrug-resistant Acinetobacter baumannii
por: Madadi-Goli, Nahid, et al.
Publicado: (2017)

Successful Treatment of Acute Prostatitis Caused by Multidrug-Resistant Escherichia coli With Tigecycline Monotherapy
por: Lo Priore, Elia, et al.
Publicado: (2020)

Effects of colistin and tigecycline on multidrug-resistant Acinetobacter baumannii biofilms: advantages and disadvantages of their combination
por: Sato, Yoshinori, et al.
Publicado: (2021)

High-Dose Tigecycline for the Treatment of Progressive Pneumonia Caused by Chlamydia psittaci: Case Series and Literature Review
por: Wang, Lu, et al.
Publicado: (2023)

Ventilator-associated pneumonia in patients with cancer: Impact of multidrug resistant bacteria
por: Cornejo-Juárez, Patricia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5ph01rqgk9vmc0h1ieljehr8d9